<VariationArchive VariationID="310846" VariationName="NM_000282.4(PCCA):c.923dup (p.Leu308fs)" VariationType="Duplication" Accession="VCV000310846" Version="24" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-06-23" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="333273" VariationID="310846">
      <GeneList>
        <Gene Symbol="PCCA" FullName="propionyl-CoA carboxylase subunit alpha" GeneID="5095" HGNC_ID="HGNC:8653" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100089093" stop="100530435" display_start="100089093" display_stop="100530435" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100741268" stop="101182690" display_start="100741268" display_stop="101182690" Strand="+" />
          </Location>
          <OMIM>232000</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000282.4(PCCA):c.923dup (p.Leu308fs)</Name>
      <CanonicalSPDI>NC_000013.11:100273197:TTTTTTT:TTTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100273197" stop="100273198" display_start="100273197" display_stop="100273198" variantLength="1" positionVCF="100273197" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100925451" stop="100925452" display_start="100925451" display_stop="100925452" variantLength="1" positionVCF="100925451" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>L308fs</ProteinChange>
      <ProteinChange>L282fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.100925458dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.100925458dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.100273204dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.100273204dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008768.1" sequenceAccession="NG_008768" sequenceVersion="1" change="g.189122dup">
            <Expression>NG_008768.1:g.189122dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.4" sequenceAccession="NM_000282" sequenceVersion="4" change="c.923dup" MANESelect="true">
            <Expression>NM_000282.4:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000273.2" sequenceAccession="NP_000273" sequenceVersion="2" change="p.Leu308fs">
            <Expression>NP_000273.2:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127692.3" sequenceAccession="NM_001127692" sequenceVersion="3" change="c.845dup">
            <Expression>NM_001127692.3:c.845dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121164.1" sequenceAccession="NP_001121164" sequenceVersion="1" change="p.Leu282fs">
            <Expression>NP_001121164.1:p.Leu282fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178004.2" sequenceAccession="NM_001178004" sequenceVersion="2" change="c.923dup">
            <Expression>NM_001178004.2:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171475.1" sequenceAccession="NP_001171475" sequenceVersion="1" change="p.Leu308fs">
            <Expression>NP_001171475.1:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352605.2" sequenceAccession="NM_001352605" sequenceVersion="2" change="c.923dup">
            <Expression>NM_001352605.2:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339534.1" sequenceAccession="NP_001339534" sequenceVersion="1" change="p.Leu308fs">
            <Expression>NP_001339534.1:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352606.2" sequenceAccession="NM_001352606" sequenceVersion="2" change="c.923dup">
            <Expression>NM_001352606.2:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339535.1" sequenceAccession="NP_001339535" sequenceVersion="1" change="p.Leu308fs">
            <Expression>NP_001339535.1:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352607.2" sequenceAccession="NM_001352607" sequenceVersion="2" change="c.845dup">
            <Expression>NM_001352607.2:c.845dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339536.1" sequenceAccession="NP_001339536" sequenceVersion="1" change="p.Leu282fs">
            <Expression>NP_001339536.1:p.Leu282fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352608.2" sequenceAccession="NM_001352608" sequenceVersion="2" change="c.845dup">
            <Expression>NM_001352608.2:c.845dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339537.1" sequenceAccession="NP_001339537" sequenceVersion="1" change="p.Leu282fs">
            <Expression>NP_001339537.1:p.Leu282fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352609.2" sequenceAccession="NM_001352609" sequenceVersion="2" change="c.923dup">
            <Expression>NM_001352609.2:c.923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339538.1" sequenceAccession="NP_001339538" sequenceVersion="1" change="p.Leu308fs">
            <Expression>NP_001339538.1:p.Leu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352610.2" sequenceAccession="NM_001352610" sequenceVersion="2" change="c.-23dup">
            <Expression>NM_001352610.2:c.-23dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352611.2" sequenceAccession="NM_001352611" sequenceVersion="2" change="c.-23dup">
            <Expression>NM_001352611.2:c.-23dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352612.2" sequenceAccession="NM_001352612" sequenceVersion="2" change="c.-23dup">
            <Expression>NM_001352612.2:c.-23dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148027.2" sequenceAccession="NR_148027" sequenceVersion="2" change="n.951dup">
            <Expression>NR_148027.2:n.951dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148028.2" sequenceAccession="NR_148028" sequenceVersion="2" change="n.951dup">
            <Expression>NR_148028.2:n.951dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148029.2" sequenceAccession="NR_148029" sequenceVersion="2" change="n.873dup">
            <Expression>NR_148029.2:n.873dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148030.2" sequenceAccession="NR_148030" sequenceVersion="2" change="n.951dup">
            <Expression>NR_148030.2:n.951dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148031.2" sequenceAccession="NR_148031" sequenceVersion="2" change="n.951dup">
            <Expression>NR_148031.2:n.951dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.3" sequenceAccession="NM_000282" sequenceVersion="3" change="c.923dup">
            <Expression>NM_000282.3:c.923dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.3" sequenceAccession="NM_000282" sequenceVersion="3" change="c.917dupT">
            <Expression>NM_000282.3:c.917dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7033453" DB="ClinGen" />
        <XRef Type="rs" ID="573607437" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000282.4(PCCA):c.923dup (p.Leu308fs) AND Propionic acidemia" Accession="RCV000335150" Version="17">
        <ClassifiedConditionList TraitSetID="3247">
          <ClassifiedCondition DB="MedGen" ID="C0268579">Propionic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-20" SubmissionCount="8">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000282.4(PCCA):c.923dup (p.Leu308fs) AND not provided" Accession="RCV001528768" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000282.4(PCCA):c.923dup (p.Leu308fs) AND PCCA-related disorder" Accession="RCV003977915" Version="2">
        <ClassifiedConditionList TraitSetID="90671">
          <ClassifiedCondition>PCCA-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-20" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12559849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15059621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15464417</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20549364</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22033733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23053474</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27825584</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27900673</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30159853</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90671" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71318" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PCCA-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PCCA-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="3247" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5805" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
                <XRef ID="Propionic+acidemia/5994" DB="Genetic Alliance" />
                <XRef ID="HP:0003571" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0011628" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycinemia, ketotic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperglycinemia with ketoacidosis and leukopenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ketotic hyperglycinemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PROP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of propionic acidemia (PA) ranges from neonatal-onset to late-onset disease. Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor feeding and decreased arousal in the first few days of life, followed by progressive encephalopathy of unexplained origin. Without prompt diagnosis and management, this is followed by progressive encephalopathy manifesting as lethargy, seizures, or coma that can result in death. It is frequently accompanied by metabolic acidosis with anion gap, lactic acidosis, ketonuria, hypoglycemia, hyperammonemia, and cytopenias. Individuals with late-onset PA may remain asymptomatic and suffer a metabolic crisis under catabolic stress (e.g., illness, surgery, fasting) or may experience a more insidious onset with the development of multiorgan complications including vomiting, protein intolerance, failure to thrive, hypotonia, developmental delays or regression, movement disorders, or cardiomyopathy. Isolated cardiomyopathy can be observed on rare occasion in the absence of clinical metabolic decompensation or neurocognitive deficits. Manifestations of neonatal and late-onset PA over time can include growth impairment, intellectual disability, seizures, basal ganglia lesions, pancreatitis, and cardiomyopathy. Other rarely reported complications include optic atrophy, hearing loss, premature ovarian insufficiency, and chronic renal failure.</Attribute>
                <XRef ID="NBK92946" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="467" />
                <XRef ID="467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22593918</ID>
                <ID Source="BookShelf">NBK92946</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2017">
                <URL>https://managementguidelines.net/guidelines.php/104/PROP%20Nutrition%20Guidelines/Version%201.2</URL>
                <CitationText>PROP Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="35" DB="Orphanet" />
              <XRef ID="C0268579" DB="MedGen" />
              <XRef ID="MONDO:0011628" DB="MONDO" />
              <XRef Type="MIM" ID="606054" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003571" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="695535" SubmissionDate="2019-04-05" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="840593" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000382013" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15059621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23053474</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27825584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30159853</ID>
          </Citation>
          <Comment>The PCCA c.923dupT (p.Leu308PhefsTer35) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Leu308PhefsTer35 variant has been reported in at least four studies in which it was identified in a total of 10 individuals affected with propionic acidemia, including in three in a homozygous state and in seven in a compound heterozygous state (Yang et al. 2004; Gallego-Villar et al. 2013; Witters et al. 2016; Molema et al. 2018). Control data are unavailable for the variant which is reported at a frequency of 0.000062 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the collective evidence, the p.Leu308PhefsTer35 variant is classified as pathogenic for propionic acidemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/d4q7wshq/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="AT" referenceAllele="A" start="100925451" stop="100925451" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.923dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5424092</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1822435" SubmissionDate="2019-05-09" DateLastUpdated="2019-07-31" DateCreated="2019-07-31">
        <ClinVarSubmissionID localKey="NM_000282.3:c.917dupT|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000929818" DateUpdated="2019-07-31" DateCreated="2019-07-31" Type="SCV" Version="1" SubmitterName="Laboratory of Metabolic Disorders, Peking University First Hospital" OrgID="505591" OrganizationCategory="laboratory" OrgAbbreviation="PKU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Chinese</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.917dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5596791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2235545" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="451446|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132451" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12559849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15059621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23053474</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20549364</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="AT" referenceAllele="A" start="100925451" stop="100925451" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2670679" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000282.3:c.923dup|MedGen:C0268579" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001362337" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15059621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12559849</ID>
          </Citation>
          <Comment>Variant summary: PCCA c.923dupT (p.Leu308PhefsX35) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. A truncation downstream of this position has been classified as pathogenic by our laboratory (c.937C&gt;T, p.Arg313X). The variant allele was found at a frequency of 3.2e-05 in 250614 control chromosomes. The variant, c.923dupT, has been reported in the literature in multiple individuals affected with Propionic Acidemia (Perez_2003, Yang_2004). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One submitter have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0268579" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3429078" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.13_100925451_100925451_A_AT|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001741085" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="AT" referenceAllele="A" start="100925451" stop="100925451" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3861725" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.13_100925451_100925451_A_AT|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001973410" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="AT" referenceAllele="A" start="100925451" stop="100925451" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4084136" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000282.4:c.923dup|Propionic acidemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002094971" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.4:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2394561" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="2779897|MedGen:C0268579" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001228999" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15464417</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12559849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20549364</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22033733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27900673</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu308Phefs*35) in the PCCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCCA are known to be pathogenic (PMID: 15464417). This variant is present in population databases (rs573607437, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with propionic acidemia (PMID: 12559849, 20549364, 22033733, 27900673). This variant is also known as 917-923insT F307fs. ClinVar contains an entry for this variant (Variation ID: 310846). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.100925451_100925452insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268579" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB6933801</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5450734" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000282.4:c.923dup|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002801629" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.4:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8876989" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="33627181|PCCA-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004788536" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PCCA c.923dupT variant is predicted to result in a frameshift and premature protein termination (p.Leu308Phefs*35). This variant was reported in multiple individuals with Propionic acidaemia (see example: reported as 917â€“923insT in Table 2, Perez et al 2003. PubMed ID: 12559849; Cappuccio G et al 2016. PubMed ID: 27900673). This variant is reported in 0.0097% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Frameshift variants in PCCA are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.3:c.923dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PCCA-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7858048" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000282.4:c.923dup|OMIM:606054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004202907" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000282.4:c.923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606054" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="695535" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1822435" TraitType="Disease" MappingType="Name" MappingValue="Propionic acidemia" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8876989" TraitType="Disease" MappingType="Name" MappingValue="PCCA-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PCCA-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3861725" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3429078" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5450734" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2670679" TraitType="Disease" MappingType="Name" MappingValue="Propionic acidemia" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2394561" TraitType="Disease" MappingType="XRef" MappingValue="C0268579" MappingRef="MedGen">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2235545" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7858048" TraitType="Disease" MappingType="XRef" MappingValue="606054" MappingRef="OMIM">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4084136" TraitType="Disease" MappingType="Name" MappingValue="Propionic acidemia" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

